UPenn Lancaster-Ann B. Barshinger Cancer Institute

Lancaster, Pennsylvania 17601

1 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer — Recruiting now